FDA official: Some patients will likely die if MS drug allowed back on market

WASHINGTON (AP) - An unknown number of patients who take a promising multiple sclerosis drug will likely die of a rare brain infection if the medicine, Tysabri, is allowed back on the market following its withdrawal last year over safety concerns, a U.S....More